WHIPgroup has filed a Complaint before the United States International Trade Commission (ITC) on behalf of its client RegenLab USA. The Complaint alleges that RegenLab’s US Pat. No. 10.064,894, directed to a blood separator system for the preparation of platelet rich plasma, has been infringed by Estar Technologies, Ltd. and Eclipse MedCorp., LLC. RegenLab is seeking an exclusion order from the ITC to prevent importation of infringing products. The ITC instituted a formal investigation on March 7, 2019. The case is captioned In the Matter of Certain Blood Separation and Cell Preparation Devices, Inv. No. 337-TA-1147.
By: Benjamin N. Luehrs Generic forum selection clauses in patent license agreements can prevent licensees from trying to invalidate licensed patents at the United States Patent and Trademark Office (USPTO). A recent Federal Circuit Opinion, [Read More…]
WHIPgroup obtained another patent allowance just by filing an Appeal Brief. The application relates to a medical shaft instrument having a force transmission element that provides torsional and axial rigidity. The Examiner had rejected the [Read More…]
By Patrick D. Duplessis These days it seems almost every article or news report about self-driving vehicles (SDVs) includes the prophecy that the automobile will soon resemble a “smartphone on wheels.” That oft-repeated phrase alludes [Read More…]